The Long-Term Effects of Conventional and Atypical Antipsychotics in Patients With Probable Alzheimer's Disease

被引:85
作者
Lopez, Oscar L. [1 ]
Becker, James T.
Chang, Yue-Fang
Sweet, Robert A.
Aizenstein, Howard
Snitz, Beth
Saxton, Judith
McDade, Eric
Kamboh, M. Ilyas
DeKosky, Steven T.
Reynolds, Charles F., III
Klunk, William E.
机构
[1] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA
关键词
LAST; 2; DECADES; CEREBROVASCULAR EVENTS; EXTRAPYRAMIDAL SIGNS; ELDERLY-PATIENTS; RATING-SCALE; DEMENTIA; RISK; MORTALITY; PSYCHOSIS; DEATH;
D O I
10.1176/appi.ajp.2013.12081046
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The authors sought to determine the effects of conventional and atypical antipsychotic use on time to nursing home admission and time to death in a group of outpatients with mild to moderate probable Alzheimer's disease. Method: The authors examined time to nursing home admission and time to death in 957 patients with the diagnosis of probable Alzheimer's disease who had at least one follow-up evaluation (mean follow-up time, 4.3 years [SD=2.7]; range, 0.78-18.0 years) using Cox proportional hazard models adjusted for age, gender, education level, dementia severity, hypertension, diabetes mellitus, heart disease, extrapyramidal signs, depression, psychosis, aggression, agitation, and dementia medication use. Results: A total of 241 patients (25%) were exposed to antipsychotics at some time during follow-up (conventional, N=138; atypical, N=95; both, N=8). Nursing home admission (63% compared with 23%) and death (69% compared with 34%) were more frequent in individuals taking conventional than atypical antipsychotics. In a model that included demographic and cognitive variables, hypertension, diabetes mellitus, heart disease, incident strokes, and extrapyramidal signs, only conventional antipsychotic use was associated with time to nursing home admission. However, the association was no longer significant after adjustment for psychiatric symptoms. Psychosis was strongly associated with nursing home admission and time to death, but neither conventional nor atypical antipsychotics were associated with time to death. Conclusions: The use of antipsychotic medications, both conventional and atypical, was not associated with either time to nursing home admission or time to death after adjustment for relevant covariates. Rather, it was the presence of psychiatric symptoms, including psychosis and agitation, that was linked to increased risk of institutionalization and death after adjustment for exposure to antipsychotics.
引用
收藏
页码:1051 / 1058
页数:8
相关论文
共 41 条
[1]  
Alexopoulos George S, 2005, Postgrad Med, VSpec No, P6
[2]  
Ballard C., 2006, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003476.PUB2, 10.1002/14651858.CD003476.pub2]
[3]   The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial [J].
Ballard, Clive ;
Hanney, Maria Luisa ;
Theodoulou, Megan ;
Douglas, Simon ;
McShane, Rupert ;
Kossakowski, Katja ;
Gill, Randeep ;
Juszczak, Edmund ;
Yu, Ly-Mee ;
Jacoby, Robin .
LANCET NEUROLOGY, 2009, 8 (02) :151-157
[4]   Cardiac and cerebrovascular morbidity and mortality associated with antipsychotic medications in elderly psychiatric inpatients [J].
Barak, Yoram ;
Baruch, Yehuda ;
Mazeh, Doron ;
Paleacu, Diana ;
Aizenberg, Dov .
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2007, 15 (04) :354-356
[5]   A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia [J].
Brodaty, H ;
Ames, D ;
Snowdon, J ;
Woodward, M ;
Kirwan, J ;
Clarnette, R ;
Lee, E ;
Lyons, B ;
Grossman, F .
JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (02) :134-143
[6]   CHARACTERIZING ORGANIC MOOD SYNDROME, DEPRESSED TYPE [J].
CORNELIUS, JR ;
FABREGA, H ;
MEZZICH, J ;
CORNELIUS, MD ;
ULRICH, RF .
COMPREHENSIVE PSYCHIATRY, 1993, 34 (06) :432-440
[7]   Relapse Risk after Discontinuation of Risperidone in Alzheimer's Disease [J].
Devanand, D. P. ;
Mintzer, Jacobo ;
Schultz, Susan K. ;
Andrews, Howard F. ;
Sultzer, David L. ;
de la Pena, Danilo ;
Gupta, Sanjay ;
Colon, Sylvia ;
Schimming, Corbett ;
Pelton, Gregory H. ;
Levin, Bruce .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (16) :1497-1507
[8]   A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease [J].
Devanand, DP ;
Marder, K ;
Michaels, KS ;
Sackeim, HA ;
Bell, K ;
Sullivan, MA ;
Cooper, TB ;
Pelton, GH ;
Mayeux, R .
AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (11) :1512-1520
[9]   Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study [J].
Gill, SS ;
Rochon, PA ;
Herrmann, N ;
Lee, PE ;
Sykora, K ;
Gunraj, N ;
Normand, SLT ;
Gurwitz, JH ;
Marras, C ;
Wodchis, WP ;
Mamdani, M .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7489) :445-448B
[10]   CEREBRAL BLOOD-FLOW IN DEMENTIA [J].
HACHINSKI, VC ;
ILIFF, LD ;
ZILHKA, E ;
DUBOULAY, GH ;
MCALLISTER, VL ;
MARSHALL, J ;
RUSSELL, RWR ;
SYMON, L .
ARCHIVES OF NEUROLOGY, 1975, 32 (09) :632-637